Holen Sie sich die Stockscreener-App
14.12
2.54%
0.35
Handel nachbörslich:
14.12
Schlusskurs vom Vortag:
$13.77
Offen:
$13.78
24-Stunden-Volumen:
1.29M
Relative Volume:
1.01
Marktkapitalisierung:
$1.10B
Einnahmen:
$1.53B
Nettoeinkommen (Verlust:
$40.23M
KGV:
28.24
EPS:
0.5
Netto-Cashflow:
$60.93M
1W Leistung:
+14.15%
1M Leistung:
+12.15%
6M Leistung:
-41.80%
1J Leistung:
-34.84%
1-Tages-Spanne:
$13.71
$14.15
1-Wochen-Bereich:
$12.38
$14.15
52-Wochen-Spanne:
$11.06
$27.13
Integra Lifesciences Holdings Corp Stock (IART) Company Profile
Firmenname
Integra Lifesciences Holdings Corp
Sektor
Branche
Telefon
(609) 275-0500
Adresse
1100 CAMPUS ROAD, PRINCETON, NJ
Vergleichen Sie IART mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IART
Integra Lifesciences Holdings Corp
|
14.12 | 993.36M | 1.53B | 40.23M | 60.93M | 0.50 |
|
ABT
Abbott Laboratories
|
129.40 | 228.63B | 43.11B | 13.98B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
102.50 | 152.25B | 18.49B | 2.51B | 3.23B | 1.68 |
|
SYK
Stryker Corp
|
378.95 | 144.00B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.91 | 118.82B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.68 | 45.89B | 5.69B | 4.14B | 577.90M | 6.96 |
Integra Lifesciences Holdings Corp Stock (IART) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-31 | Hochstufung | Argus | Hold → Buy |
| 2024-12-02 | Eingeleitet | Morgan Stanley | Underweight |
| 2024-10-07 | Hochstufung | BTIG Research | Sell → Neutral |
| 2024-07-30 | Herabstufung | BTIG Research | Neutral → Sell |
| 2024-07-30 | Herabstufung | Citigroup | Neutral → Sell |
| 2024-05-07 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2024-05-07 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-04-03 | Hochstufung | Citigroup | Sell → Neutral |
| 2023-12-05 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-11-14 | Eingeleitet | CL King | Buy |
| 2023-08-24 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2023-07-12 | Hochstufung | Jefferies | Hold → Buy |
| 2023-06-08 | Herabstufung | Argus | Buy → Hold |
| 2023-05-24 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2023-05-23 | Herabstufung | Citigroup | Neutral → Sell |
| 2022-10-12 | Eingeleitet | Jefferies | Hold |
| 2022-07-25 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2022-04-13 | Herabstufung | Truist | Buy → Hold |
| 2021-12-17 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2021-09-15 | Herabstufung | BTIG Research | Buy → Neutral |
| 2020-10-08 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2020-05-27 | Eingeleitet | Citigroup | Neutral |
| 2020-04-03 | Eingeleitet | SunTrust | Buy |
| 2020-01-07 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2020-01-07 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2019-01-03 | Eingeleitet | SunTrust | Buy |
| 2018-11-28 | Eingeleitet | UBS | Neutral |
| 2018-08-07 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2018-07-26 | Hochstufung | BTIG Research | Neutral → Buy |
| 2018-07-02 | Herabstufung | Citigroup | Buy → Neutral |
| 2018-01-05 | Fortgesetzt | Cantor Fitzgerald | Neutral |
| 2018-01-02 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2017-11-09 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2017-10-30 | Herabstufung | Wells Fargo | Outperform → Market Perform |
| 2017-10-27 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2017-06-30 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2017-05-02 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2017-01-13 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2017-01-06 | Hochstufung | JMP Securities | Mkt Perform → Mkt Outperform |
| 2016-12-12 | Eingeleitet | UBS | Buy |
Alle ansehen
Integra Lifesciences Holdings Corp Aktie (IART) Neueste Nachrichten
5 Must-Read Analyst Questions From Integra LifeSciences’s Q2 Earnings Call - ca.finance.yahoo.com
Developing predictive dashboards with Integra LifeSciences Holdings Corporation dataCEO Change & Free Community Consensus Stock Picks - Newser
Integra LifeSciences Holdings Corporation’s volatility index tracking explained2025 Trading Recap & Daily Stock Trend Reports - Newser
IART Q2 2025 Deep Dive: Operational Transformation and Supply Recovery Shape Outlook - ca.finance.yahoo.com
Using data models to predict Integra LifeSciences Holdings Corporation stock movementFree Access to Real-Time Trade Insights - Newser
Technical analysis overview for Integra LifeSciences Holdings Corporation stock [Quarterly Growth Report]Free Weekly High Potential Stock Alerts - Newser
Why Integra LifeSciences Holdings Corporation stock attracts strong analyst attentionBuy Zone Strategy with Pattern Recognition - Newser
Price action breakdown for Integra LifeSciences Holdings CorporationShort-Term Upside Breakout Forecast System - Newser
Integra LifeSciences Holdings Corporation stock daily chart insightsConsistent Profit Signals with AI Models - Newser
Top chart patterns to watch in Integra LifeSciences Holdings CorporationBreakout Stock Opportunities with Low Drawdown - Newser
Is now a turning point for Integra LifeSciences Holdings CorporationFree Multi-Bagger Potential Stock Forecast Tools - Newser
Published on: 2025-08-10 02:52:05 - Newser
What’s the recovery path for long term holders of Integra LifeSciences Holdings CorporationShort-Term AI-Based Stock Price Forecast - Newser
What makes Integra LifeSciences Holdings Corporation stock price move sharplyBreakout Stock Opportunities with Low Drawdown - Newser
Technical analysis overview for Integra LifeSciences Holdings Corporation stockPortfolio Building Plan and Summary Guide - Newser
Evaluating Integra LifeSciences Holdings Corporation with trendline analysisTriple Digit Gain Opportunity Watchlist - newser.com
Integra LifeSciences Holdings Corporation (NASDAQ:IART) Q2 2025 Earnings Call Transcript - Insider Monkey
Has Integra LifeSciences Holdings Corporation Stock Ever Crashed Historical Volatility ReviewFree Intraday Trend Analysis for Fast Gains - Newser
Integra LifeSciences Holdings Corporation Company’s Quarterly Earnings Growth: What the Numbers SayFree Swing Trading Plan With Smart Signals - Newser
JMP reiterates Market Outperform rating on Integra LifeSciences stock By Investing.com - Investing.com Canada
JMP reiterates Market Outperform rating on Integra LifeSciences stock - Investing.com
KLP Kapitalforvaltning AS Cuts Stake in Integra LifeSciences Holdings Corporation (NASDAQ:IART) - Defense World
How Integra LifeSciences Holdings Corporation stock performs during market volatilityBuy and Hold Return Summary with Charts - Newser
Integra: Q2 Earnings Snapshot - Norwalk Hour
Earnings call transcript: Integra LifeSciences Q2 2025 beats EPS expectations By Investing.com - Investing.com Canada
Earnings call transcript: Integra LifeSciences Q2 2025 beats EPS expectations - Investing.com
Integra Lifesciences Holdings Corp reports results for the quarter ended June 30Earnings Summary - TradingView
Integra LifeSciences Q2 2025 slides: Revenue dips, projects second-half rebound - Investing.com Canada
Integra LifeSciences (IART) Beats Q2 Earnings and Revenue Estimates - Yahoo Finance
Integra Lifesciences Holdings Corp Reports Q2 Revenue of $415.6M - GuruFocus
Integra LifeSciences (IART) Reports Strong Q2 Revenue Performanc - GuruFocus
Integra Lifesciences Holdings Corp Reports Q2 Revenue of $415.6M, Exceeding Estimates; Adjusted EPS at $0.45, Surpassing Expectations - GuruFocus
Integra LifeSciences (NASDAQ:IART) Beats Q2 Sales Targets - Yahoo Finance
Integra Lifesciences Topped Revenue Estimates Despite Investor Caution - Finimize
Integra LifeSciences Reports Second Quarter 2025 Financial Results - TradingView
Integra LifeSciences (IART) Reports Strong Q2 Revenue Performance - GuruFocus
Integra Lifesciences Holdings Corp to Report Q2 2025 Earnings on July 31, 2025 with Expected Revenue of $395.07 Million and Earnings of $0.00 per Share - AInvest
Earnings To Watch: Integra Lifesciences Holdings Corp (IART) Reports Q2 2025 Result - Yahoo Finance
Allianz Asset Management GmbH Buys 71,939 Shares of Integra LifeSciences Holdings Corporation (NASDAQ:IART) - Defense World
Yiren Digital Releases 2024 ESG Report, Achieving 5% Greenhouse Gas Reduction and Preventing RMB 180 Million in Fraudulent Loans with AI Model. - AInvest
Integra LifeSciences (IART) Reports Q2: Everything You Need To Know Ahead Of Earnings - Yahoo.co
Published on: 2025-07-29 18:17:19 - metal.it
Cwm LLC Boosts Position in Integra LifeSciences Holdings Corporation (NASDAQ:IART) - Defense World
Published on: 2025-07-28 21:45:23 - metal.it
Should I hold or sell Integra LifeSciences Holdings Corporation stock in 2025Discover breakthrough investment opportunities - Jammu Links News
What is Integra LifeSciences Holdings Corporation company’s growth strategyGet alerts on the hottest stocks daily - jammulinksnews.com
How Efficient Is Integra LifeSciences Holdings Corporation at Controlling Operating CostsFast Growing Stocks - Newser
Finanzdaten der Integra Lifesciences Holdings Corp-Aktie (IART)
Umsatz
Nettogewinn
Free Cashflow
ENV
Integra Lifesciences Holdings Corp-Aktie (IART) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Singh Harvinder | EVP & PRESIDENT, INTERNATIONAL |
Mar 10 '25 |
Option Exercise |
0.00 |
1,180 |
0 |
2,359 |
| Schwartz Eric | EVP, Chief Legal Officer & Sec |
Dec 03 '24 |
Sale |
24.59 |
4,070 |
100,102 |
59,511 |
0.31%
1.36%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):